Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
CG Oncology, Inc.
| Metric | CG Oncology, Inc. CGONHealthcare |
|---|---|
| Quality Score | 67 / 100 |
| Revenue (latest) | $4M |
| Net income (latest) | −$161M |
| Operating margin | −4722.1% |
| Net margin | −3985.0% |
| Return on equity | −21.4% |
| Return on assets | −20.3% |
| Return on capital (ROCE) | −25.1% |
| Debt / equity | 0.05× |
| Revenue growth (YoY) | 254.7% |
| Altman Z″ (distress) | 23.13 |
| Accruals / assets | −3.6% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.